Discussion on the influence of nanoparticle characteristics in New Coronavirus Disease-19 and severe acute respiratory syndrome Coronavirus 2
<p>In the paper, why New Coronavirus Disease-19 (COVID-19) should belong to a class of protein nanoparticle and possessed ultra-small size and super-penetration capability, as well as effect of the COVID-19 characteristic on follows phenomena were discussed. (1) The difference existed on toxic...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications,
2021-03-31.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | peertech__10_17352_2455-3492_000043 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Shenguo Wang |e author |
| 245 | 0 | 0 | |a Discussion on the influence of nanoparticle characteristics in New Coronavirus Disease-19 and severe acute respiratory syndrome Coronavirus 2 |
| 260 | |b International Journal of Nanomaterials, Nanotechnology and Nanomedicine - Peertechz Publications, |c 2021-03-31. | ||
| 520 | |a <p>In the paper, why New Coronavirus Disease-19 (COVID-19) should belong to a class of protein nanoparticle and possessed ultra-small size and super-penetration capability, as well as effect of the COVID-19 characteristic on follows phenomena were discussed. (1) The difference existed on toxicity, transmission speed and diffusion range of the COVID-19 and Severe acute respiratory syndrome (Sars) virus. (2) The different time interval between COVID-19 infection and discover existed in different person. (3) The different time interval in "new crown virus infection", "asymptomatic infection", "suspected case" and "re-infection" produced existed in different person. (4) The different time interval from COVID-19 infection to produce SARS‑CoV‑2 disease existed in different person. The improve methods and suggestion for avoiding and preventing COVID-19 infection and treating SARS‑CoV‑2 were proposed. </p> | ||
| 540 | |a Copyright © Shenguo Wang et al. | ||
| 546 | |a en | ||
| 655 | 7 | |a Review Article |2 local | |
| 856 | 4 | 1 | |u https://doi.org/10.17352/2455-3492.000043 |z Connect to this object online. |